Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell Malignances
Latest Information Update: 05 Jun 2023
At a glance
- Drugs Anti-CD7 chimeric antigen receptor cell therapy-iCell Gene Therapeutics (Primary)
- Indications T-cell leukaemia; T-cell lymphoma
- Focus Adverse reactions
- Sponsors iCell Gene Therapeutics
- 25 Jun 2021 New trial record